BRAF and melanoma: In the present study we show that the melanoma specific immunotoxin 9.2.27PE in combination with the BH-3 mimetic ABT-737, caused strong synergistic cytotoxic effect in the panel of melanoma cells, independently of their BRAF status and, as previously reported [20], their sensitivity to Dacarbazine.